(Q34652269)

3 August 2017

Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2. (English)

1 reference

3 August 2017

1 reference

1

Hideki Sakai

1 reference

3 August 2017

Tomoyuki Suzuki

2

1 reference

3 August 2017

Yuji Takahashi

3

1 reference

3 August 2017

Masashi Ukai

4

1 reference

3 August 2017

Katsunori Tauchi

5

1 reference

3 August 2017

Takuto Fujii

6

1 reference

3 August 2017

Naoki Horikawa

7

1 reference

3 August 2017

Tetsuji Minamimura

8

1 reference

3 August 2017

Yoshiaki Tabuchi

9

1 reference

3 August 2017

Magotoshi Morii

10

1 reference

3 August 2017

Kazuhiro Tsukada

11

1 reference

3 August 2017

Noriaki Takeguchi

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

11 May 2006

1 reference

3 August 2017

1 reference

3 August 2017

580

1 reference

3 August 2017

14

1 reference

3 August 2017

3368-3374

1 reference

New chemotherapy approaches in colorectal cancer

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Cancer epidemiology in the last century and the next decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

The role of cyclooxygenases in inflammation, cancer, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

The role of prostaglandins and other eicosanoids in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Colorectal cancer chemoprevention--an overview of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

COX-2 inhibitors--lessons in drug safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Cyclic AMP-dependent Cl- secretion induced by thromboxane A2 in isolated human colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Nitric oxide-induced Cl- secretion in isolated rat colon is mediated by the release of thromboxane A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Is the ClC-2 chloride channel involved in the Cl- secretory mechanism of gastric parietal cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Up-regulation of Na(+),K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Immunohistochemical studies of blood group-related antigens in human superficial esophageal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene Superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Cancer research. Anti-inflammatories inhibit cancer growth--but how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

OKY-1581, a potential selective thromboxane synthetase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.05.007

10.1016/J.FEBSLET.2006.05.007

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference